Sep. 1—The Tahlequah Regional Development Authority has seven-member board that makes decisions on management, operation and development of the Tahlequah Industrial Park and Cherokee County. TRDA ...

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have ...

Shares of Entrada Therapeutics, Inc. TRDA were down 32.1% in after-market trading on Dec 19 after the company announced that it received a clinical hold notice from the FDA regarding its ...

Shares of Entrada Therapeutics, Inc. TRDA rallied 18.51% after the company announced a collaboration deal with biotech giant Vertex Pharmaceuticals, Inc. VRTX. Both companies have collaborated to ...

) has been revised to $16.83 / share. This is a decrease of 10.81% from the prior estimate of $18.87 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...

Entrada Therapeutics, Inc. (TRDA) shares ended the last trading session 5.6% higher at $6.64. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Entrada Therapeutics, Inc. (TRDA) shares rallied 10.4% in the last trading session to close at $17.37. This move can be attributable to notable volume with a higher number of shares being traded than ...

The TRDA listing reveals that the device has 22021211RG model number, and also confirms its POCO F4 moniker. The device has previously been spotted on the NBTC certification site as well as Geekbench ...

Entrada Therapeutics, Inc. (TRDA) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...

Entrada Therapeutics Inc. Annual cash flow by MarketWatch. View TRDA net cash flow, operating cash flow, operating expenses and cash dividends.